US2020237787A1PendingUtilityA1
Anti-Inflammatory Compounds and Uses Thereof
Assignee: MEDICON PHARMACEUTICALS INCPriority: Aug 10, 2007Filed: Apr 20, 2020Published: Jul 30, 2020
Est. expiryAug 10, 2027(~1 yrs left)· nominal 20-yr term from priority
Inventors:Basil Rigas
C07F 9/091A61P 29/00A61P 37/02A61P 25/28A61P 11/02A61P 9/00A61P 11/08A61P 9/10A61P 35/00C07F 9/094A61K 31/6615A61K 31/661A61P 13/08C07F 9/093A61P 19/02A61P 9/12A61P 35/02A61P 9/14A61P 27/02A61P 25/00C07F 9/65742A61P 11/00A61P 43/00A61P 1/04A61P 37/00A61P 19/04A61P 37/06
71
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
are disclosed with activity towards treating diseases related to inflammation, such as cancer, neurodegenerative and cardiovascular diseases. Pharmaceutical compositions and methods of use are also described.
Claims
exact text as granted — not AI-modified1 .- 19 . (canceled)
20 . A method of treating a disease or disorder in a subject in need thereof, the method comprising administering to the subject a composition comprising a pharmaceutically acceptable excipient and a compound of Formula (I):
or a salt thereof, wherein in Formula (I):
A is selected from the group consisting of:
B is selected from the group consisting of:
D is
and
n is 1 or 2.
21 . The method of claim 20 , wherein the disease or disorder is selected from an inflammation related disease or disorder, a neurodegenerative disease or disorder, an autoimmune disease or disorder, and a proliferative disease or disorder.
22 . The method of claim 20 , wherein the inflammation related disease or disorder is selected from a rheumatologic disease, a cardiovascular disease, a neurodegenerative disease, a cerebrovascular disease, an autoimmune disease, a chronic inflammation disease, a neoplastic disease, and a pre-neoplastic disease.
23 . The method of claim 21 , wherein the proliferative disease or disorder is cancer.
24 . The method of claim 23 , wherein the cancer is selected from prostate cancer, colon adenomas, colon cancer, lung cancer, breast cancer, pancreatic cancer, lymphoma and leukemia.
25 . The method of claim 20 , wherein the compound of Formula (I) is:
26 . The method of claim 20 , wherein the compound of Formula (I) is:
27 . The method of claim 24 , wherein the cancer is prostate cancer.
28 . The method of claim 24 , wherein the cancer is colon adenomas.
29 . The method of claim 24 , wherein the cancer is colon cancer.
30 . The method of claim 24 , wherein the cancer is lung cancer.
31 . The method of claim 24 , wherein the cancer is breast cancer.
32 . The method of claim 24 , wherein the cancer is pancreatic cancer.
33 . The method of claim 24 , wherein the cancer is lymphoma.
34 . The method of claim 24 , wherein the cancer is leukemia.Join the waitlist — get patent alerts
Track US2020237787A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.